2007
Smoke and mirrors: Magnified beliefs that cigarette smoking suppresses weight
White MA, McKee SA, O'Malley SS. Smoke and mirrors: Magnified beliefs that cigarette smoking suppresses weight. Addictive Behaviors 2007, 32: 2200-2210. PMID: 17428615, PMCID: PMC1993360, DOI: 10.1016/j.addbeh.2007.02.011.Peer-Reviewed Original ResearchConceptsSmoking Consequences Questionnaire-AdultWeight concernsWeight-concerned smokersAbility of smokingControl scoresBingeing Severity ScaleWeight-concerned individualsEffectiveness of smokingBody dissatisfactionLoss of controlActual weight gainMagical thinkingExaggerated beliefsPrevious quit attemptsSmoking cessationWeight gainQuit attemptsWeight control strategiesCessation trialTemporary abilitySuppress body weightFood rulesCurrent studyPerceived RiskBeliefs
2006
A Controlled Trial of Naltrexone Augmentation of Nicotine Replacement Therapy for Smoking Cessation
O’Malley S, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P. A Controlled Trial of Naltrexone Augmentation of Nicotine Replacement Therapy for Smoking Cessation. JAMA Internal Medicine 2006, 166: 667-674. PMID: 16567607, DOI: 10.1001/archinte.166.6.667.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAdministration, OralAmbulatory CareDose-Response Relationship, DrugDouble-Blind MethodDrug Therapy, CombinationFemaleHumansLinear ModelsMaleMiddle AgedNaltrexoneNarcotic AntagonistsNicotineNicotinic AgonistsSmoking CessationSubstance Withdrawal SyndromeSurveys and QuestionnairesTreatment OutcomeWeight GainConceptsNicotine patch therapyNicotine patchPatch therapyDouble-blind placebo-controlled trialHigher continuous abstinence ratesLow-dose naltrexone therapyNaltrexone hydrochlorideWeight gainTreatment completersOral naltrexone hydrochlorideOutpatient research centerWeight-concerned smokersContinuous abstinence ratesPlacebo-controlled trialPrimary end pointSecond-line treatmentNicotine replacement therapyNaltrexone augmentationNaltrexone therapyPlacebo groupQuit dateTreat analysisAbstinence ratesReplacement therapySmoking cessation